sh-Oligopeptide-4 for Hair Regrowth

Created on 11/08/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

sh-Oligopeptide-4, the cosmetic name for a laboratory-made copy of a natural repair protein, is sold in hair serums and a clinic injection mix for thinning hair. In rodents it speeds hair regrowth, but every human hair study used a multi-ingredient scalp injection, almost all from its developers, and none tested it alone. Safety over weeks is reassuring; a longer-term tumor question remains open. It sits at the experimental edge. (Full Review)

Protocol

Clinic injection protocol (QR678 Neo)
1.5 mL every 4 weeks
Injected into the scalp for 8 sessions
Cosmetic serums and shampoos
Typically once daily
Per product label, to a dry scalp; concentrations rarely disclosed
Topical scalp gel
0.5 mg/mL every other day
For 4 weeks; the regimen tested for scalp dermatitis
Time to effect
Injection course (hair)
Roughly 2–7 months
Assessed after the 4th and 8th sessions and 2 months later
Scalp flaking (gel)
From first follow-up
Flaking fell more than placebo at every follow-up through week 24

Benefits

Contraindications
  • Active or recent cancer
  • Pregnancy and breastfeeding
  • Bleeding disorders, for needle delivery only
  • Active scalp infection or open lesions, for needle delivery only
Key Interactions
Theoretical (inferred from mechanism)
  • Anticoagulants and antiplatelet drugs (warfarin, apixaban, clopidogrel)
  • Over-the-counter pain relievers that impair clotting (aspirin, ibuprofen, naproxen)
  • Angiogenesis inhibitors (bevacizumab, ramucirumab)
  • Copper peptides and growth-factor serums (GHK-Cu, platelet-rich plasma)
  • Hair supplements (saw palmetto, pumpkin seed oil)

Risk & Side Effects

  • High:
  • Medium: Local skin reactions
  • Low: Injection and microneedling discomfort; tumor promotion
  • Speculative: Mislabeled or substituted unregulated products

Monitoring

Marker Target Why
Terminal hair count (trichoscopy) No established target; track change from the individual's own baseline Primary outcome in QR678 Neo trials
Hair shaft diameter (trichoscopy) No established target; track change from the individual's own baseline Thicker shafts signal reversal of follicle shrinking
Hair pull test No established target; track change from the individual's own baseline Marker of active shedding
Scalp redness and itching (skin check) No established target; any persistent reaction is relevant Safety check: persistent reaction stops use

Cadence: Baseline, then photographs and trichoscopy at 3, 6 and 12 months; skin check after each application week in the first month

Qualitative Assessment

  • Visible scalp coverage in standardized photographs
  • Amount of hair shed on the pillow, in the shower and when brushing
  • Hair volume and styling ease
  • Scalp comfort, flaking and itch